Kalshi to allow bets on clinical trials, FDA decisions
Read the full articleYou might also wanna read
Kalshi to allow bets on clinical trials, FDA decisions
July 16 (Reuters) - Prediction market platform Kalshi will start taking bets on the outcomes of clinical trials and FDA regulatory reviews,
Kalshi to offer betting on drug trial results and FDA regulatory decisions
Move comes as prediction platforms rapidly gain popularity and offer opportunities to bet on virtually anything Kalshi is expanding its wage
STAT+: Pharmalittle: We’re reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more
Kalshi, one of the world’s largest prediction market exchanges, plans to take bets on clinical trials and regulatory approvals
Kalshi Launches Prediction Markets for Clinical Trials and FDA Decisions
Prediction market Kalshi and public intelligence company AppliedXL have launched a pilot program that allows trading on clinical trial outco
STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals
Prediction markets have permeated the worlds of sports, politics, and reality television shows. Now, the biopharma industry could be next.
Kalshi hits pause on flight cancellation contracts
The prediction markets company has planned to offer the wagers as a way to hedge travel risks, but critics warned the contracts could be mis
Comments
Sign in to join the conversation.
No comments yet. Be the first.